Status:
ENROLLING_BY_INVITATION
The Effect of Computerized Vestibular Function Assessment and Training System Combined With Cognitive/Motor Dual-task
Lead Sponsor:
Taipei Medical University
Conditions:
Vestibular Function Disorder
Cognitive Decline
Eligibility:
All Genders
55-85 years
Phase:
NA
Brief Summary
This study aims to investigate the effect of computerized vestibular function assessment and interactive training system, combined with cognitive/motor dual-task for the elderly with dizziness. The in...
Detailed Description
Dizziness is one of the most common complaints among older adults and often a concern within healthcare systems. It leads to distressing sensations, reduced mobility, and decreased quality of life. Di...
Eligibility Criteria
Inclusion
- Year 1 (Study A):
- Could walk more than 30 meters with or without walking aids independently.
- Able to comprehend and communicate in Mandarin or Taiwanese.
- Sufficient corrected vision that allows independent outdoor mobility.
- Year 2 (Study B):
- Could walk more than 30 meters with or without walking aids independently.
- Able to comprehend and communicate in Mandarin or Taiwanese.
- Sufficient corrected vision that allows independent outdoor mobility.
- Healthy participants and those who have experienced dizziness or falls within the past two years.
- Year 3 (Study C):
- Could walk more than 30 meters with or without walking aids independently.
- Able to comprehend and communicate in Mandarin or Taiwanese.
- Sufficient corrected vision that allows independent outdoor mobility.
- Willing to engage in moderate-intensity exercise for 45 minutes per session.
- Participants who have experienced dizziness or falls within the past two years.
Exclusion
- Year 1 (Study A):
- Severe central or peripheral nervous system disorders.
- Participants who are blind or deaf.
- Individuals who cannot communicate or understand instructions.
- Current fractures or significant joint injuries.
- Year 2 (Study B):
- Severe central or peripheral nervous system disorders.
- Participants who are blind or deaf.
- Individuals who cannot communicate or understand instructions.
- Current fractures or significant joint injuries.
- Year 3 (Study C):
- Severe central or peripheral nervous system disorders.
- Participants who are blind or deaf.
- Individuals who cannot communicate or understand instructions.
- Current fractures or significant joint injuries.
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 14 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05990023
Start Date
November 1 2023
End Date
May 14 2026
Last Update
November 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Medical University
Taipei, Taiwan